Posted in | News | Medical Sensor

APAC Market for Self Monitoring of Blood Glucose Remains Underserved

Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly 200 million for the self monitoring of blood glucose (SMBG) market. However, not more than 45 percent of these patients have been diagnosed, which represents a vast underserved market.

New analysis from Frost & Sullivan (https://www.medtech.org/), APAC Self Monitoring of Blood Glucose (SMBG) Market, finds that the meter segment earned US$222.7 million in 2012 market and is expected to reach US$358.7 million in 2017. The strip segment earned revenues of US$1212.7 million 2012 and expects this to grow to US$2081.2 million in 2017.

Less than 10 percent of the diabetic population in Asia-Pacific use SMBG products due to inadequate education and awareness, as well as a lack of affordability and strict regulations. To improve patient awareness, SMBG original equipment manufacturers (OEMs), several governmental and non-governmental organizations, and hospitals conduct patient awareness camps and drives throughout the year.

"The high costs of frequent testing also deter patients from investing in SMBG devices thus lowering compliance," said Frost & Sullivan Healthcare Senior Industry Analyst Nitin Dixit. "SMBG devices are mostly an out-of-pocket expense in Asia-Pacific, as the meters and strips are reimbursed only in a handful of countries in the region. While one-time cost of buying a meter is relatively low, buying test strips for frequent testing can prove very expensive, especially for patients on 'intensive diabetes management therapy', unless reimbursed."

Market participants can leverage the ubiquity of the Internet and smartphones in Asia-Pacific to gain a competitive edge by launching diabetes data management software as a value-added service. Data from individuals' SMBG meters can be shared with consulting doctors over the Internet, who can then suggest changes in medication/diet accordingly. "Roche, for instance, experienced higher sales with the recent launches of products enabled with data management software," noted Dixit.

Differentiating from competition will become even more vital as SMBG gradually becomes a low-value, high-volume segment due to intense competition and the resultant price wars. It is important to maintain adequate shelf space (availability) in the retail segment, as patients may switch brands if the prescribed brand is unavailable.

"There are many non-invasive or painless meters in the later stages of clinical trials, and some are already commercially available," said Dixit. "The introduction of these products with novel features will go a long way in helping OEMs shed their commodity status and stand out in the market."

If you are interested in more information on this research, please send an e-mail to Donna Jeremiah, Corporate Communications, at [email protected], with your full name, company name, job title, telephone number, company e-mail address, company website, city, state and country.

APAC Self Monitoring of Blood Glucose (SMBG) Market is part of the Advanced Medical Technologies Growth Partnership Service program. Frost & Sullivan's related research services include: U.S. Magnetic Resonance Imaging (MRI) Systems Market, European Interventional Radiology and Cardiology Market, Cardiac Rhythm Device Market in Mexico, and U.S. Breast Imaging Systems Market. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Frost & Sullivan. (2022, June 30). APAC Market for Self Monitoring of Blood Glucose Remains Underserved. AZoSensors. Retrieved on December 04, 2024 from https://www.azosensors.com/news.aspx?newsID=6302.

  • MLA

    Frost & Sullivan. "APAC Market for Self Monitoring of Blood Glucose Remains Underserved". AZoSensors. 04 December 2024. <https://www.azosensors.com/news.aspx?newsID=6302>.

  • Chicago

    Frost & Sullivan. "APAC Market for Self Monitoring of Blood Glucose Remains Underserved". AZoSensors. https://www.azosensors.com/news.aspx?newsID=6302. (accessed December 04, 2024).

  • Harvard

    Frost & Sullivan. 2022. APAC Market for Self Monitoring of Blood Glucose Remains Underserved. AZoSensors, viewed 04 December 2024, https://www.azosensors.com/news.aspx?newsID=6302.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.